Inglasia Pharma Solutions is a Global GMP consultancy serving the pharmaceutical and biotechnology industry.
We have expertise in US FDA, EMA, UK MHRA and World Health Organisation standards on Good Manufacturing Practice. Since 2011, we have been supporting Global medicines manufacturers in …
This free training video on Good Distribution Practice is based on EU GDP 2013/C 343/01 guidelines and World Health Organisation, Technical Report Series 1025 – Annex 7: Good storage and distribution practices for medical products.
This short, but succinct, video explains why there is t…
Departments and external stakeholders must work together to expedite recalls
The above process overview highlights the main considerations when executing a medicinal product recall. When a notification of a recall is received by the MAH (marketing authorisation holder in Country for the medici…
People working in freight forwarding handle all kinds of products. Some of the goods handled are medicines.
A brown box can hold any type of goods so how do we differentiate and what precautionary measures would we apply to medicines?
This introductory video gives some insight on our train…
Minimum checks required on medicinal product imported from an *EEA Country by a business in Great Britain (GB)
If your business in GB is looking to import medicinal products from the EEA, there are a number of checks which must be performed by the Responsible Person, prior to release for sale …
This short training video takes you through the preparations for a Good Distribution Practice audit in accordance with EU GDP 2013/C 343/01. It also discusses the key areas to consider when performing the audit and the documents that should be reviewed during the audit.
If you would like more…
We use cookies to improve user experience and analyse website traffic. By clicking “Accept“, you agree to our website's cookie use as described in our Cookie Policy.
